{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:26:51Z","timestamp":1777573611761,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.schres.2018.11.007","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T09:46:02Z","timestamp":1542879962000},"page":"257-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Characteristics and outcomes of young people with substance induced psychotic disorder"],"prefix":"10.1016","volume":"206","author":[{"given":"Jessica","family":"O'Connell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Sunwoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"McGorry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6240-6952","authenticated-orcid":false,"given":"Brian","family":"O'Donoghue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.schres.2018.11.007_bb0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/070674370805300311","article-title":"Measuring schizophrenia remission in clinical practice","volume":"53","author":"Alonso","year":"2008","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.schres.2018.11.007_bb6005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.schres.2018.11.007_bb0010","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1192\/bjp.187.6.510","article-title":"Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases","volume":"187","author":"Arendt","year":"2005","journal-title":"Br. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2018.11.007_bb0015","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/archpsyc.65.11.1269","article-title":"Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia","volume":"65","author":"Arendt","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2018.11.007_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archpsyc.62.2.137","article-title":"Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses","volume":"62","author":"Caton","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2018.11.007_bb0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1192\/bjp.bp.105.015784","article-title":"Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis","volume":"190","author":"Caton","year":"2007","journal-title":"Br. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2018.11.007_bb0030","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00127-008-0490-2","article-title":"First-episode drug-induced psychosis: a medium term follow up study reveals a high-risk group","volume":"44","author":"Crebbin","year":"2009","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"2","key":"10.1016\/j.schres.2018.11.007_bb0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-0447.2006.00783.x","article-title":"Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis","volume":"114","author":"Edwards","year":"2006","journal-title":"Acta Psychiatr. Scand."},{"issue":"1-3","key":"10.1016\/j.schres.2018.11.007_bb6010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.schres.2012.01.022","article-title":"Differentiating first episode substance induced and primary psychotic disorders with concurrent substance use in young people","volume":"136","author":"Fraser","year":"2012","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2018.11.007_bb0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/j.1440-1614.2000.00728.x","article-title":"Psychotic disorders in urban areas: an overview of the study on low prevalence disorders","volume":"34","author":"Jablensky","year":"2000","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2018.11.007_bb0045","series-title":"The Recognition and Management of Early Psychosis: a Preventive Approach","author":"Jackson","year":"2009"},{"issue":"7","key":"10.1016\/j.schres.2018.11.007_bb0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s001270050240","article-title":"Early detection and assertive community treatment of young psychotics: the opus study rationale and design of the trial","volume":"35","author":"Jorgensen","year":"2000","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"5","key":"10.1016\/j.schres.2018.11.007_bb0055","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00127-017-1343-7","article-title":"Waiting time variation in early intervention psychosis services: longitudinal evidence from the SEPEA naturalistic cohort study","volume":"52","author":"Kirkbride","year":"2017","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"2","key":"10.1016\/j.schres.2018.11.007_bb0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-0447.2005.00554.x","article-title":"The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis","volume":"112","author":"Lambert","year":"2005","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.schres.2018.11.007_bb0065","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archgenpsychiatry.2011.5","article-title":"Cannabis use and earlier onset of psychosis: a systematic meta-analysis","volume":"68","author":"Large","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2018.11.007_bb0070","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4088\/JCP.v69n0304","article-title":"Substance-induced psychosis: a diagnostic conundrum","volume":"69","author":"Mathias","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2018.11.007_bb0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ajp.2017.04.014","article-title":"Primary psychosis with comorbid drug abuse and drug-induced psychosis: diagnostic and clinical evaluation at follow up","volume":"29","author":"Mauri","year":"2017","journal-title":"Asian J. Psychiatr."},{"issue":"9","key":"10.1016\/j.schres.2018.11.007_bb0080","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4088\/JCP.08r04472","article-title":"Intervention in individuals at ultra-high risk for psychosis: a review and future directions","volume":"70","author":"McGorry","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2018.11.007_bb6000","series-title":"Early Intervention (EI) Acceptance Criteria Guidelines","article-title":"National Early Intervention Programme","author":"National Institute for Mental Health in England","year":"2008"},{"issue":"8","key":"10.1016\/j.schres.2018.11.007_bb0085","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/jamapsychiatry.2013.1270","article-title":"Long-term follow-up of a group at ultra high risk (\u201cprodromal\u201d) for psychosis: the PACE 400 study","volume":"70","author":"Nelson","year":"2013","journal-title":"JAMA Psychiat."},{"issue":"1","key":"10.1016\/j.schres.2018.11.007_bb0090","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.4088\/JCP.12m07822","article-title":"Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases","volume":"74","author":"Niemi-Pynttari","year":"2013","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2018.11.007_bb0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1034\/j.1600-0447.2002.1o079.x","article-title":"Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia","volume":"105","author":"Nunez","year":"2002","journal-title":"Acta Psychiatr. Scand."},{"issue":"1\u20132","key":"10.1016\/j.schres.2018.11.007_bb0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.schres.2015.07.004","article-title":"Environmental factors and the age at onset in first episode psychosis","volume":"168","author":"O'Donoghue","year":"2015","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2018.11.007_bb0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/acps.12623","article-title":"Short-term outcome of substance-induced psychotic disorder in a large UK first episode psychosis cohort","volume":"134","author":"Thompson","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.schres.2018.11.007_bb0110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1176\/appi.ajp.162.2.401","article-title":"Cannabis use and schizophrenia","volume":"162","author":"Wade","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2018.11.007_bb0115","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.bp.105.017236","article-title":"Substance misuse in first-episode psychosis: 15-month prospective follow-up study","volume":"189","author":"Wade","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2018.11.007_bb0120","article-title":"Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: a systematic review","author":"Wilson","year":"2017","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418306376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418306376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T16:29:28Z","timestamp":1558542568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996418306376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":27,"alternative-id":["S0920996418306376"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2018.11.007","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and outcomes of young people with substance induced psychotic disorder","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2018.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}